8156 — Sinopharm Tech Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- HK$23.15m
- HK$18.46m
- HK$42.84m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 6.65 | 6.75 | 7.48 | 2.99 | 1.78 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 30.2 | 34.2 | 26.6 | 42.4 | 22.9 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 41.3 | 62.1 | 49.6 | 48.1 | 27 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.57 | 37.8 | 28.3 | 5.19 | 1.16 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 229 | 188 | 136 | 76.9 | 33.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 189 | 254 | 273 | 250 | 213 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Liabilities | 191 | 261 | 275 | 244 | 206 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 37.7 | -73.1 | -139 | -167 | -173 |
Total Liabilities & Shareholders' Equity | 229 | 188 | 136 | 76.9 | 33.5 |
Total Common Shares Outstanding |